The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials.
Wheatley-Price, Paul
The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer May 2010 - 640-8 p. digital
Publication Type: Journal Article
1556-1380
10.1097/JTO.0b013e3181d40a1b doi
Adenocarcinoma--drug therapy
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Canada
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Squamous Cell--drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Female
Humans
Lung Neoplasms--mortality
Male
Neoplasm Staging
Quality of Life
Randomized Controlled Trials as Topic
Retrospective Studies
Sex Factors
Treatment Outcome
The influence of sex on efficacy, adverse events, quality of life, and delivery of treatment in National Cancer Institute of Canada Clinical Trials Group non-small cell lung cancer chemotherapy trials. [electronic resource] - Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer May 2010 - 640-8 p. digital
Publication Type: Journal Article
1556-1380
10.1097/JTO.0b013e3181d40a1b doi
Adenocarcinoma--drug therapy
Aged
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Canada
Carcinoma, Non-Small-Cell Lung--drug therapy
Carcinoma, Squamous Cell--drug therapy
Chemotherapy, Adjuvant
Clinical Trials, Phase III as Topic
Female
Humans
Lung Neoplasms--mortality
Male
Neoplasm Staging
Quality of Life
Randomized Controlled Trials as Topic
Retrospective Studies
Sex Factors
Treatment Outcome